Anjali Vaidya, MD, FACC, FASE, FACP

Articles by Anjali Vaidya, MD, FACC, FASE, FACP

Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD

ByMaggie L. Shaw,Anjali Vaidya, MD, FACC, FASE, FACP

September 17th 2025

New findings reveal sotatercept's significant benefits for right ventricular function and tricuspid regurgitation in pulmonary arterial hypertension.

New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide

ByMaggie L. Shaw,Anjali Vaidya, MD, FACC, FASE, FACP

June 4th 2025

Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.

Anjali Vaidya, MD, FACC, FASE, FACP

Articles by Anjali Vaidya, MD, FACC, FASE, FACP

Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD

New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide

Latest Updated Articles

Trending on AJMC

Iron Dysregulation Linked to MS Progression, Review Finds

FDA Approves Use of Subcutaneous Pembrolizumab for NSCLC

FDA Approves Ruxolitinib Cream for Patients as Young as 2 Years With Atopic Dermatitis

Second Known Case of Concurrent ET, WM Raises Questions About Their Coexistence

Pirtobrutinib Shows Clinically Meaningful PFS Improvement in Frontline CLL